MINODIAB

This brand name is authorized in Spain, Mexico, United Kingdom

Active ingredients

The drug MINODIAB contains one active pharmaceutical ingredient (API):

1 Glipizide
UNII X7WDT95N5C - GLIPIZIDE

Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class. The primary mode of action of glipizide is the stimulation of insulin secretion from the beta-cells of pancreatic islet tissue.

Read about Glipizide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MINODIAB Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BB07 Glipizide A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 51293
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 20527
Country: MX Comisiรณn Federal para la Protecciรณn contra Riesgos Sanitarios Identifier(s): 79341

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.